Q32 Bio (QTTB) Long-Term Investments (2022 - 2025)
Q32 Bio's quarterly Long-Term Investments came in at $2.5 million in Q1 2025, down 46.53% year-on-year from $4.7 million in Q1 2024, and down 2.85% quarter-over-quarter from $2.6 million in Q4 2024.
Q32 Bio has reported Long-Term Investments for 4 years, with the latest figure at $2.5 million in Q1 2025.
- For the quarter ending Q1 2025, Long-Term Investments fell 46.53% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2025 stood at $2.5 million (down 46.53% YoY), and the FY2024 full-year result was $2.6 million, changed N/A from the prior year.
- Long-Term Investments for Q1 2025 stood at $2.5 million, down from $2.6 million in the prior quarter.
- The five-year high for Long-Term Investments was $30.6 million in Q1 2022, with the low at $2.5 million in Q1 2025.
- Average Long-Term Investments over 4 years is $15.2 million, with a median of $15.7 million recorded in 2023.
- Year-over-year, Long-Term Investments slipped 24.93% in 2023 and sank 81.43% in 2024.
- Tracing QTTB's Long-Term Investments over 4 years: stood at $25.8 million in 2022, then slumped by 45.77% to $14.0 million in 2023, then slumped by 81.43% to $2.6 million in 2024, then decreased by 2.85% to $2.5 million in 2025.
- The last three Long-Term Investments figures came in at $2.5 million (Q1 2025), $2.6 million (Q4 2024), and $2.6 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 3.28 Mn |
| Mar 31, 2024 | 4.72 Mn |
| Sep 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 17.32 Mn |
| Mar 31, 2023 | 23.00 Mn |
| Dec 31, 2022 | 25.81 Mn |
| Sep 30, 2022 | 27.13 Mn |
| Jun 30, 2022 | 29.30 Mn |
| Mar 31, 2022 | 30.64 Mn |